161 related articles for article (PubMed ID: 35238098)
1. Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer.
Xu Y; Wang H; Wang T; Chen C; Sun R; Yao W; Ma Y; Zhang Q; Wu L; Zeng S; Sun X
Cancer Sci; 2022 May; 113(5):1739-1751. PubMed ID: 35238098
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive profile of TCF1
Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
4. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.
Chen Z; Ji Z; Ngiow SF; Manne S; Cai Z; Huang AC; Johnson J; Staupe RP; Bengsch B; Xu C; Yu S; Kurachi M; Herati RS; Vella LA; Baxter AE; Wu JE; Khan O; Beltra JC; Giles JR; Stelekati E; McLane LM; Lau CW; Yang X; Berger SL; Vahedi G; Ji H; Wherry EJ
Immunity; 2019 Nov; 51(5):840-855.e5. PubMed ID: 31606264
[TBL] [Abstract][Full Text] [Related]
5. CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with
Diupotex M; Zamora-Chimal J; Gajón JA; Bonifaz LC; Becker I
Front Immunol; 2023; 14():1231836. PubMed ID: 37691941
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
[TBL] [Abstract][Full Text] [Related]
7. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
8. Identification of a T-bet
Raju S; Xia Y; Daniel B; Yost KE; Bradshaw E; Tonc E; Verbaro DJ; Kometani K; Yokoyama WM; Kurosaki T; Satpathy AT; Egawa T
J Immunol; 2021 Jun; 206(12):2924-2936. PubMed ID: 34088768
[TBL] [Abstract][Full Text] [Related]
9. Id2 epigenetically controls CD8
Li Y; Han M; Wei H; Huang W; Chen Z; Zhang T; Qian M; Jing L; Nan G; Sun X; Dai S; Wang K; Jiang J; Zhu P; Chen L
Cell Mol Immunol; 2024 Mar; 21(3):292-308. PubMed ID: 38287103
[TBL] [Abstract][Full Text] [Related]
10. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
11. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
12. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
13. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Sawada M; Goto K; Morimoto-Okazawa A; Haruna M; Yamamoto K; Yamamoto Y; Nakagawa S; Hiramatsu K; Matsuzaki S; Kobayashi E; Kawashima A; Hirata M; Iwahori K; Kimura T; Ueda Y; Kimura T; Wada H
Int Immunol; 2020 May; 32(6):397-405. PubMed ID: 32009163
[TBL] [Abstract][Full Text] [Related]
14. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
15. mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection.
Ando S; Perkins CM; Sajiki Y; Chastain C; Valanparambil RM; Wieland A; Hudson WH; Hashimoto M; Ramalingam SS; Freeman GJ; Ahmed R; Araki K
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36378537
[TBL] [Abstract][Full Text] [Related]
16. Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models.
Li X; Li Y; Dong L; Chang Y; Zhang X; Wang C; Chen M; Bo X; Chen H; Han W; Nie J
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36853831
[TBL] [Abstract][Full Text] [Related]
17. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
[TBL] [Abstract][Full Text] [Related]
18. Stat5 opposes the transcription factor Tox and rewires exhausted CD8
Beltra JC; Abdel-Hakeem MS; Manne S; Zhang Z; Huang H; Kurachi M; Su L; Picton L; Ngiow SF; Muroyama Y; Casella V; Huang YJ; Giles JR; Mathew D; Belman J; Klapholz M; Decaluwe H; Huang AC; Berger SL; Garcia KC; Wherry EJ
Immunity; 2023 Dec; 56(12):2699-2718.e11. PubMed ID: 38091951
[TBL] [Abstract][Full Text] [Related]
19. Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer.
Kuo WT; Kuo IY; Hsieh HC; Wu ST; Su WC; Wang YC
J Biomed Sci; 2024 Feb; 31(1):20. PubMed ID: 38321486
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
